Insmed (INSM) News Today $159.03 +0.75 (+0.47%) As of 02:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INSM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period ERS 2025: Brinsupri’s efficacy reinforced in subgroup analysis of bronchiectasis patients5 hours ago | yahoo.com111 Capital Makes New Investment in Insmed, Inc. $INSMOctober 7 at 4:04 AM | marketbeat.comChung Wu Investment Group LLC Takes $173,000 Position in Insmed, Inc. $INSMOctober 6 at 5:46 AM | marketbeat.comInsmed (NASDAQ:INSM) Price Target Raised to $196.00October 6 at 2:43 AM | americanbankingnews.comEvercore ISI Remains a Buy on Insmed (INSM)October 4 at 6:36 PM | theglobeandmail.comInsmed (INSM) Gets a Buy from Leerink PartnersOctober 4 at 6:36 PM | theglobeandmail.comHow Analysts Are Rethinking Insmed After Brinsupri’s Approval and New Revenue ProjectionsOctober 4 at 1:36 PM | finance.yahoo.comGoldman Sachs Maintains Insmed (INSM) Buy RecommendationOctober 4 at 8:34 AM | msn.comInsmed (NASDAQ:INSM) Hits New 52-Week High on Analyst UpgradeOctober 4 at 2:57 AM | americanbankingnews.comInsmed (NASDAQ:INSM) Stock Price Expected to Rise, TD Cowen Analyst SaysOctober 4 at 2:21 AM | americanbankingnews.comInsmed (NASDAQ:INSM) Price Target Raised to $196.00 at The Goldman Sachs GroupOctober 3, 2025 | marketbeat.comTD Cowen Maintains Insmed (INSM) Buy RecommendationOctober 3, 2025 | msn.comAnalyst Expectations For Insmed's FutureOctober 2, 2025 | benzinga.comInsmed price target raised to $193 from $154 at TD CowenOctober 2, 2025 | msn.comInsmed (NASDAQ:INSM) Sets New 1-Year High After Analyst UpgradeOctober 2, 2025 | marketbeat.comOhio Retirement Fund Invests in Insmed Incorporated (INSM)October 2, 2025 | insidermonkey.comTD Cowen Issues Positive Forecast for Insmed (NASDAQ:INSM) Stock PriceOctober 2, 2025 | marketbeat.comInsmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9%October 1, 2025 | finance.yahoo.comInsmed price target raised to $180 from $110 at Evercore ISIOctober 1, 2025 | msn.comInsmed: De-Risked Respiratory Growth, Premium Multiple, And Real M&A OptionalitySeptember 30, 2025 | seekingalpha.comInsmed Incorporated (INSM) Rallies After FDA Approves Brinsupri, Shares Jump 9%September 30, 2025 | insidermonkey.comPublic Employees Retirement System of Ohio Makes New Investment in Insmed, Inc. $INSMSeptember 29, 2025 | marketbeat.comRBC Capital Remains Bullish on Insmed Incorporated (INSM)September 27, 2025 | msn.comSpotlight on Insmed: Analyzing the Surge in Options ActivitySeptember 25, 2025 | benzinga.comAssenagon Asset Management S.A. Buys 33,626 Shares of Insmed, Inc. $INSMSeptember 24, 2025 | marketbeat.comInsmed to present multiple abstracts from ERS Congress 2025September 22, 2025 | msn.comInsmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025September 22, 2025 | prnewswire.comLongboard Asset Management LP Invests $205,000 in Insmed, Inc. $INSMSeptember 19, 2025 | marketbeat.comHarbor Capital Advisors Inc. Cuts Position in Insmed, Inc. $INSMSeptember 18, 2025 | marketbeat.comFinanciere des Professionnels Fonds d investissement inc. Makes New Investment in Insmed, Inc. $INSMSeptember 18, 2025 | marketbeat.comRep. Gilbert Ray Cisneros, Jr. Sells Insmed, Inc. (NASDAQ:INSM) SharesSeptember 17, 2025 | marketbeat.comTracking Baker Brothers Portfolio - Q2 2025 UpdateSeptember 17, 2025 | seekingalpha.comStrs Ohio Buys Shares of 25,700 Insmed, Inc. $INSMSeptember 17, 2025 | marketbeat.comInsmed (NASDAQ:INSM) Director Sells $1,453,900.00 in StockSeptember 16, 2025 | marketbeat.comOrlov Nicole Schaeffer Sells 76,520 Shares of Insmed (NASDAQ:INSM) StockSeptember 16, 2025 | marketbeat.comInsmed (NASDAQ:INSM) Trading Down 3.4% - Time to Sell?September 16, 2025 | marketbeat.comInsmed (NASDAQ:INSM) Director Melvin Md Sharoky Sells 10,000 SharesSeptember 16, 2025 | insidertrades.comUBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Has $41.16 Million Stake in Insmed, Inc. $INSMSeptember 16, 2025 | marketbeat.comCaxton Associates LLP Acquires New Shares in Insmed, Inc. $INSMSeptember 15, 2025 | marketbeat.comGoldman Sachs Group Inc. Sells 352,728 Shares of Insmed, Inc. $INSMSeptember 15, 2025 | marketbeat.comInsmed, Inc. (NASDAQ:INSM) Given Average Recommendation of "Moderate Buy" by AnalystsSeptember 15, 2025 | marketbeat.comIntech Investment Management LLC Has $7.78 Million Holdings in Insmed, Inc. $INSMSeptember 14, 2025 | marketbeat.comWoodline Partners LP Buys 86,540 Shares of Insmed, Inc. $INSMSeptember 13, 2025 | marketbeat.comNon-Cystic Fibrosis Bronchiectasis Market Expected to Gain Momentum Through 2034, According to DelveInsight | Insmed, AstraZeneca, Zambion, The Marcus Foundation, Chiesi ...September 12, 2025 | theglobeandmail.comInsmed (INSM) Reported Impressive Results from the Phase 2 Trial of Its Inhalation PowderSeptember 12, 2025 | insidermonkey.comBayforest Capital Ltd Raises Holdings in Insmed, Inc. $INSMSeptember 12, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Increases Stock Position in Insmed, Inc. $INSMSeptember 12, 2025 | marketbeat.comRoyal Bank of Canada Has $18.71 Million Stake in Insmed, Inc. $INSMSeptember 12, 2025 | marketbeat.comInsmed Incorporated (INSM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 10, 2025 | seekingalpha.comInsmed (NASDAQ:INSM) Reaches New 12-Month High After Analyst UpgradeSeptember 10, 2025 | marketbeat.com Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Videos INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼0.670.54▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼2319▲INSM Articles Average Week Get the Latest News and Ratings for INSM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Insmed and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Sanofi News Today GSK News Today Takeda Pharmaceutical News Today argenex News Today BeOne Medicines News Today BioNTech News Today Teva Pharmaceutical Industries News Today Genmab A/S News Today Summit Therapeutics News Today Ascendis Pharma A/S News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
